BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1566 related articles for article (PubMed ID: 25282285)

  • 1. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].
    Sun Q; Huang Y; Zhao SJ; Zhang L; Tang W; Jin YJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):274-279. PubMed ID: 29730914
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study.
    Gheysens G; De Wever W; Cockmartin L; Bosmans H; Coudyzer W; De Vuysere S; Lefere M
    Eur Radiol; 2022 Jul; 32(7):4437-4445. PubMed ID: 35238969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of lung nodules detected by volume CT scanning.
    van Klaveren RJ; Oudkerk M; Prokop M; Scholten ET; Nackaerts K; Vernhout R; van Iersel CA; van den Bergh KA; van 't Westeinde S; van der Aalst C; Thunnissen E; Xu DM; Wang Y; Zhao Y; Gietema HA; de Hoop BJ; Groen HJ; de Bock GH; van Ooijen P; Weenink C; Verschakelen J; Lammers JW; Timens W; Willebrand D; Vink A; Mali W; de Koning HJ
    N Engl J Med; 2009 Dec; 361(23):2221-9. PubMed ID: 19955524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
    Hammer MM; Byrne SC
    AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
    [No Abstract]   [Full Text] [Related]  

  • 15. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the optimum definition of growth evaluation for indeterminate pulmonary nodules detected in lung cancer screening.
    Lee JH; Hwang EJ; Lim WH; Goo JM
    PLoS One; 2022; 17(9):e0274583. PubMed ID: 36108077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Screening CT-Detected Nodule Volumetry as a Function of Size.
    Liang M; Yip R; Tang W; Xu D; Reeves A; Henschke CI; Yankelevitz DF
    AJR Am J Roentgenol; 2017 Aug; 209(2):304-308. PubMed ID: 28570098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
    Heuvelmans MA; Walter JE; Vliegenthart R; van Ooijen PMA; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2018 Aug; 73(8):779-781. PubMed ID: 29056601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.
    de Hoop B; van Ginneken B; Gietema H; Prokop M
    Radiology; 2012 Nov; 265(2):611-6. PubMed ID: 22929331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.